Infectious diseases, like Malaria, tuberculosis, HIV and Ebola, continue to be a leading cause of death among humans, especially in developing countries. Attempts to develop vaccines against these pathogens using traditional methods have been unsuccessful.
New vaccine technologies and approaches, such as the heterologous prime-boost (HPB) strategy, have opened the door to the development of vaccines against these challenging pathogens. However, while promising with respect to addressing unmet medical needs, HPB is accompanied by manufacturing, regulatory, logistical and access challenges.
In order to establish policy pathways for successful development and implementation of HPB strategies, general consensus about the potential medical benefits of such strategies is urgently needed. To that end, the One Health Platform invites you to a one-day high-level scientific colloquium in Leuven, Belgium, on 29 September 2017.